Jul 19, 2022, 09:30 AM by

The global Single-Use Bioprocessing market gathered revenue around USD 21.98 billion in 2021 and market is set to grow USD 84.12 billion by the end of 2030 and is estimated to expand at a modest CAGR of 16.1% during the prediction period 2022 to 2030.

Jul 19, 2022, 09:05 AM by User Not Found

Bio-IT World | A team of biologists and engineers from the Universities of Michigan and Wisconsin used a synthetic human gut microbiome to study the interactions between intestinal microbial communities. Their findings lay the groundwork for designer microbiomes with target functions.

Jul 18, 2022, 09:40 AM by

The Global biotechnology market size was valued at US$ 1,023.93 billion in 2021 and is expected to hit US$ 3,879.52 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.11% from 2022 to 2030.

Jul 18, 2022, 09:39 AM by

The global artificial intelligence (AI) in healthcare market size is projected to reach US$ 187.95 billion by 2030 at a steady CAGR of 37% from 2022 to 2030.

Jul 15, 2022, 09:38 AM by

The major driving force of the efficacy testing market is the increasing pharmaceutical and biotechnology industry driven by government support and the positive trend in the research and development work in the life science sector.

Jul 15, 2022, 09:37 AM by

According to Precedence Research, the US behavioral health market is predicted to hit around USD 132.4 billion by 2027 from valued at USD 90.5 billion in 2020 and growing at a CAGR of 5.32% between 2021 and 2027.

Jul 15, 2022, 09:36 AM by

The AI in drug discovery market size is projected to reach US$ 11.9 billion by 2030 at a steady CAGR of 29.62% from 2022 to 2030.

Jul 15, 2022, 09:36 AM by

Jul 15, 2022, 01:00 AM by User Not Found

Bio-IT World | Historically, the heavily regulated biopharma industry has been slow to adopt new technologies. However, a shift toward automation is vital to ensure that next-generation solutions produce at scale.

Jul 14, 2022, 12:16 PM by

BRIM Biotechnology, Inc. (BRIM, TWSE 6885) entered OTC trading in Taiwan on 23rd June 2022, CST. The news was announced at the company’s first earnings call on 22nd June 2022.

Jul 14, 2022, 09:32 AM by

The CRISPR genome editing market is classified into by applications, end-user, and geography.

Jul 14, 2022, 09:31 AM by

Flywheel, the leading data management platform for biomedical research and collaboration, is adding two new solutions to its product suite. Flywheel Trial Flow and Flywheel Discovery will give researchers new ways to streamline clinical trials, plus discover patient cohorts and analyze data on an enterprise scale.

Jul 14, 2022, 09:31 AM by

Jul 14, 2022, 09:30 AM by

About Sharp Sharp is a global leader in clinical supply chain services and pharmaceutical packaging. For more than 65 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver. Through our partnership with Berkshire Sterile Manufacturing we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization. Our full complement of integrated services includes: research and development, clinical manufacturing, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage and distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of the EU and UK.

Jul 14, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers at the Department of Energy’s Oak Ridge National Laboratory have definitively linked the function of a specific domain of proteins to the activation—and deactivation—of the c-MET pathway, which leads to the progression of tumor growth and metastatic cancer cells. Mutating any of four proteins blocks pathway progression.

Jul 13, 2022, 09:24 AM by

The organisers of Connect in Pharma announce today that for every visitor to the Geneva-based event, five Swiss francs will be donated to EspeRare Foundation, a not-for-profit organisation that identifies, develops and promotes access to life-changing treatments and technologies for patients affected by rare diseases.

Jul 13, 2022, 09:23 AM by

The bioprocess containers market is segmented based on by type, by application, by end user and by geography.

Jul 13, 2022, 09:21 AM by

The global gene therapy market is expected to grow to $5.02B by 2028. It’s slated to be the fastest growing investive market in the world over the next 5 years. Helping fuel this growth, Discovery Life Sciences, the biospecimen and biomarker specialists, has acquired AllCells, a leading provider of clinical-grade (GMP-compliant) and Research Use Only primary cell products. With more than 30 years of joint cell and gene therapy experience, the two companies' combined solutions will: Establish the premier provider for critical starting materials and analytic services to accelerate CGT applications Create one of the industry's largest dedicated client donor pools Provide a “one-stop-shop” for revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum Offer continuity for every stage of development, spanning RUO and GMP grade fresh, cryopreserved, and mobilized leukoplaks, as well as immune cell isolations, diseased biospecimens, and expert analytical service Effective immediately, AllCells CEO and President Danny Zheng will lead the combined entity. I’m happy to set up an interview with him to discuss the news in further detail. Thank you and please feel free to reach out with questions -

Jul 12, 2022, 09:37 AM by

The global precision medicine software market is driven by growing research in genomics/precision medicine, significant VC fundings, rising government support and the rapid shift toward personalized treatments.

Jul 12, 2022, 09:35 AM by

Its new Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.